Rx Drug Policy At The FDA: Looking Back At Gottlieb And Ahead To Sharpless

By Scott Gottlieb (Original source Health Affairs)

“This week is expected to be Dr. Scott Gottlieb’s last as Commissioner of the U.S. Food and Drug Administration (FDA). During his nearly two years in the position, Commissioner Gottlieb has confronted a range of public health challenges, including the opioid epidemic, an increase in teen nicotine abuse, and natural disasters (as this Blog has already considered).”

Click here to see more